🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 12 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Fuzhou

← All China trials

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

10
Recruiting now
14
Active studies
Recruiting Phase 1
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors
Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · started 2026-01-22
📍 Beijing · Fuzhou · Meizhou · Shanghai · Chengdu
NCT07269145 on ClinicalTrials.gov ↗
Recruiting Phase 2
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital · started 2025-10-25
📍 Fuzhou · Putian · Quanzhou · Sanming · Xiamen · Zhangzhou
NCT07296705 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Janssen Research & Development, LLC · started 2025-10-01
📍 Beijing · Changzhou · Cheng Du Shi · Chongqing · Foshan · Fuzhou
NCT07196748 on ClinicalTrials.gov ↗
Recruiting Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Bristol-Myers Squibb · started 2025-09-22
📍 Bengbu · Beijing · Chongqing · Fuzhou · Guangzhou · Shenzhen
NCT07116967 on ClinicalTrials.gov ↗
Active Phase 2
A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B
Chronic Hepatitis B
Shanghai Argo Biopharmaceutical Co., Ltd. · started 2025-09-02
📍 Hefei · Beijing · Sichuan · Chongqing · Fuzhou · Guangzhou
NCT07135349 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Akeso · started 2025-08-14
📍 Beijing · Fuzhou · Shijiazhuang · Harbin · Shanghai · Tianjin
NCT07023315 on ClinicalTrials.gov ↗
Recruiting
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
Prostate Cancer Screening, PSMA-PET
First Affiliated Hospital of Fujian Medical University · started 2025-05-07
📍 Fuzhou
NCT06923657 on ClinicalTrials.gov ↗
Recruiting Phase 3
QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
Nasopharyngeal Cancinoma (NPC), Nasopharyngeal Cancer
Sun Yat-Sen University Cancer Center · started 2025-05-04
📍 Fuzhou · Dongguan · Foshan · Guangzhou · Zhongshan · Nanning
NCT06749899 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China · started 2025-03-03
📍 Hefei · Chongqing · Fuzhou · Guangzhou · Nanning · Guiyang
NCT06882057 on ClinicalTrials.gov ↗
By invitation
Morphological-Gene-Clinical Phenotype Correlation Study of the Long Anterior Zonule
Long Anterior Zonules
Fuzhou Eye Hospital · started 2025-01-10
📍 Fuzhou
NCT07549711 on ClinicalTrials.gov ↗
Recruiting Phase 4
Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)
Aneurysmal Subarachnoid Hemorrhage
Second Affiliated Hospital of Nanchang University · started 2024-03-28
📍 Hefei · Heihe · Fuzhou · Guangzhou · Harbin · Zhengzhou
NCT06284642 on ClinicalTrials.gov ↗
By invitation Phase 3
A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Stereotypical Prolonged Seizures
UCB Biopharma SRL · started 2022-02-03
📍 Beijing · Changchun · Chengdu · Chongqing · Fuzhou · Guangzhou
NCT05076617 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Myasthenia Gravis
Janssen Research & Development, LLC · started 2021-07-15
📍 Beijing · Changchun · Changsha · Chengdu · Fuzhou · Guangzhou
NCT04951622 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Medullary Thyroid Cancer
Loxo Oncology, Inc. · started 2020-02-11
📍 Hefei · Beijing · Chongqing · Fuzhou · Lanzhou · Guangzhou
NCT04211337 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Beijing · 65 Guangzhou · 30 Shanghai · 28 Fuzhou · 14 Chengdu · 14 Changsha · 13 Shenzhen · 12 Hangzhou · 11 Tianjin · 10 Wuhan · 9 Chongqing · 8 Changchun · 7

Browse by condition

Breast Cancer · 5 Artificial Intelligence (AI) · 2 Healthy · 2 Aneurysmal Subarachnoid Hemorrhage · 2 Prostate Cancer · 2 Nasopharyngeal Cancinoma (NPC) · 2 Solid Tumors · 2 Healthy Participants · 2 Ischemic Stroke · 2 Wet Age-related Macular Degenerat… · 2 Plaque Psoriasis · 2 Solid Tumor · 2 Colorectal Cancer · 2 Gastric Cancer · 2 Lung Cancer (NSCLC) · 2 Pulmonary Function · 2
Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china/city/fuzhou (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.